Decompression and Posterior Enucleation of a Unicystic Ameloblastoma-Granular Cell Variant. Case Report
##plugins.themes.bootstrap3.article.details##
The ameloblastoma is one of the most agressive and localy destructive benign tumors of the human body, capable of producing enormous deformations of the face in a short period of time. In its classification the unicystic variant is consider less agresive and allows a conservative treatment. We present a case of 20 years old female patient, with a unicystic ameloblastoma with a granular cells variant, which was managed in a conservative way, with a two month decompression and a posterior enucleation, with a one year follow up. This treatment is less morbid than the surgical resection with safety margins, avoiding big stetical and functional defects.
ameloblastoma cystic, granular cells, decompresssion, enucleationameloblastoma, células granulares, descompresión, enucleación
2. Motahhary P, Etebarian A, Asareh F. Granular cell type of a unicystic ameloblastoma: An unusual case and review of the literature. J Oral Maxillofac Pathol JOMFP. 2014 May;18(2):331.
3. Robinson L, Martinez MG. Unicystic ameloblastoma: a prognostically distinct entity. Cancer. 1977 Nov;40(5):2278-85.
4. Nikolaos G. Nikitakis, Tzerbos F, Triantafyllou K, Papadimas C, Sklavounou A. Granular cell ameloblastoma: an unusual histological subtype report and review of literature. J Oral Maxillofac Res [Internet]. 2011 Jan 1 [cited 2016 Mar 28];1(4). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886069/
5. Philipsen HP, Reichart PA. Unicystic ameloblastoma: A review of 193 cases from the literature. Oral Oncol. 1998 Sep;34(5):317-25.
6. Larsson A, Almerén H. Ameloblastoma of the jaws: An analysis of a consecutive series of all cases reported to the Swedish Cancer Registry during 1958-1971. Acta Pathol Microbiol Scand [A]. 1978 Sep;86A(5):337-49.
7. Koneru A, Hallikeri K, Nellithady GS, Krishnapillai R, Prabhu S. Immunohistochemical expression of calretinin in ameloblastoma, adenomatoid odontogenic tumor, and keratocystic odontogenic tumor: A comparative study. Appl Immunohistochem Mol Morphol AIMM Off Publ Soc Appl Immunohistochem. 2014 Dec;22(10):762-7.
8. Ghandhi D, Ayoub AF, Pogrel MA, MacDonald G, Brocklebank LM, Moos KF. Ameloblastoma: a surgeon’s dilemma. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg. 2006 Jul;64(7):1010-4.
9. Carlson ER, Marx RE. The ameloblastoma: primary, curative surgical management. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg. 2006 Mar;64(3):484-94.
10. Prasad K, Lalitha RM, Ranganath K, Srikar MV, Dexith J, Sagar P, et al. Unicystic ameloblastoma, a distinct clinical entity with favorable response to decompression: Our experience of 5 cases. J Oral Maxillofac Surg Med Pathol. 2013 Oct;25(4):328-32.
11. Lau SL, Samman N. Recurrence related to treatment modalities of unicystic ameloblastoma: a systematic review. Int J Oral Maxillofac Surg. 2006 Aug;35(8):681-90.
12. Nakamura N, Higuchi Y, Tashiro H, Ohishi M. Marsupialization of cystic ameloblastoma: a clinical and histopathologic study of the growth characteristics before and after marsupialization. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg. 1995 Jul;53(7):748-54; discussion 755-6.